All In Biotech

Drug Trial Radar · NCT06215586

Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 303 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

303

Actual

Start

Feb 13, 2024

Primary completion

Sep 2, 2025

Study completion Sep 2, 2025

Sponsor

Sponsor type
Industry
First posted
Jan 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart failure with preserved ejection fraction

Conditions

  • Heart Failure
  • Heart Failure Preserved Ejection Fraction
  • Cardiovascular Diseases
  • Heart Diseases

Interventions

  • Tovinontrine (CRD-750)Drug

    Tablet administered orally

  • PlaceboDrug

    Tablet administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in biomarkers from Baseline to Week 12 - NT-proBNPTime frame: Baseline to Week 12

Locations

84 sites in 15 countries. Site status is shown where the registry gives one.

  • Cardurion Investigative Site

    Birmingham, Alabama

  • Cardurion Investigative Site

    Little Rock, Arkansas

  • Cardurion Investigative Site

    Orange, California

  • Cardurion Investigative Site

    Torrance, California

  • Cardurion Investigative Site

    Van Nuys, California

  • Cardurion Investigative Site

    Jacksonville, Florida

  • Cardurion Investigative Site

    Miami, Florida

  • Cardurion Investigative Site

    Hazel Crest, Illinois

  • Cardurion Investigative Site

    Peoria, Illinois

  • Cardurion Investigative Site

    Alexandria, Louisiana

  • Cardurion Investigative Site

    Covington, Louisiana

  • Cardurion Investigative Site

    St Louis, Missouri

  • Cardurion Investigative Site

    Buffalo, New York

  • Cardurion Investigative Site

    New York, New York

  • Cardurion Investigative Site

    Cleveland, Ohio

  • Cardurion Investigative Site

    Oklahoma City, Oklahoma

  • Cardurion Investigative Site

    Portland, Oregon

  • Cardurion Investigative Site

    Rapid City, South Dakota

  • Cardurion Investigative Site

    Nashville, Tennessee

  • Cardurion Investigative Site

    Dallas, Texas

  • Cardurion Investigative Site

    McKinney, Texas

  • Cardurion Investigative Site

    Burlington, Vermont

  • Cardurion Investigative Site

    Chermside, Australia

  • Cardurion Investigative Site

    Bruges, Belgium

  • Cardurion Investigative Site

    Sint-Niklaas, Belgium

  • Cardurion Investigative Site

    Burgas, Bulgaria

  • Cardurion Investigative Site

    Gabrovo, Bulgaria

  • Cardurion Investigative Site

    Plovdiv, Bulgaria

  • Cardurion Investigative Site

    Plovdiv, Bulgaria

  • Cardurion Investigative Site

    Rousse, Bulgaria

  • Cardurion Investigative Site

    Sofia, Bulgaria

  • Cardurion Investigative Site

    Stara Zagora, Bulgaria

  • Cardurion Investigative Site

    Cambridge, Ontario, Canada

  • Cardurion Investigative Site

    Hamilton, Ontario, Canada

  • Cardurion Investigative Site

    Chicoutimi, Quebec, Canada

  • Cardurion Investigative Site

    Montreal, Quebec, Canada

  • Cardurion Investigative Site

    Sherbrooke, Quebec, Canada

  • Cardurion Investigative Site

    Trois-Rivières, Quebec, Canada

  • Cardurion Investigative Site

    Hradec Králové, Czechia

  • Cardurion Investigative Site

    Hradec Králové, Czechia

Showing 40 of 84 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.